294 related articles for article (PubMed ID: 10852646)
1. Lisinopril: a review of its use in congestive heart failure.
Simpson K; Jarvis B
Drugs; 2000 May; 59(5):1149-67. PubMed ID: 10852646
[TBL] [Abstract][Full Text] [Related]
2. Lisinopril. A review of its pharmacology and clinical efficacy in elderly patients.
Langtry HD; Markham A
Drugs Aging; 1997 Feb; 10(2):131-66. PubMed ID: 9061270
[TBL] [Abstract][Full Text] [Related]
3. Lisinopril. A review of its pharmacology and clinical efficacy in the early management of acute myocardial infarction.
Goa KL; Balfour JA; Zuanetti G
Drugs; 1996 Oct; 52(4):564-88. PubMed ID: 8891468
[TBL] [Abstract][Full Text] [Related]
4. Do evidence-based treatments provide incremental benefits to patients with congestive heart failure already receiving angiotensin-converting enzyme inhibitors? A secondary analysis of one-year outcomes from the Assessment of Treatment with Lisinopril and Survival (ATLAS) study.
Majumdar SR; McAlister FA; Cree M; Chang WC; Packer M; Armstrong PW;
Clin Ther; 2004 May; 26(5):694-703. PubMed ID: 15220013
[TBL] [Abstract][Full Text] [Related]
5. [Lisinopril in the treatment of heart insufficiency].
Barcina Sánchez C; Martín Cortés M; Fernández Fernández A
An Med Interna; 1995 May; 12(5):246-53. PubMed ID: 7669880
[TBL] [Abstract][Full Text] [Related]
6. Toleration of high doses of angiotensin-converting enzyme inhibitors in patients with chronic heart failure: results from the ATLAS trial. The Assessment of Treatment with Lisinopril and Survival.
Massie BM; Armstrong PW; Cleland JG; Horowitz JD; Packer M; Poole-Wilson PA; Rydén L
Arch Intern Med; 2001 Jan; 161(2):165-71. PubMed ID: 11176729
[TBL] [Abstract][Full Text] [Related]
7. [Clinical study of the month. The ATLAS study].
Kulbertus H
Rev Med Liege; 1999 Dec; 54(12):952-4. PubMed ID: 10686803
[TBL] [Abstract][Full Text] [Related]
8. Short- and long-acting angiotensin-converting enzyme inhibitors: a randomized trial of lisinopril versus captopril in the treatment of congestive heart failure. The Multicenter Lisinopril-Captopril Congestive Heart Failure Study Group.
Giles TD; Katz R; Sullivan JM; Wolfson P; Haugland M; Kirlin P; Powers E; Rich S; Hackshaw B; Chiaramida A
J Am Coll Cardiol; 1989 May; 13(6):1240-7. PubMed ID: 2539403
[TBL] [Abstract][Full Text] [Related]
9. Comparison of vasopeptidase inhibitor, omapatrilat, and lisinopril on exercise tolerance and morbidity in patients with heart failure: IMPRESS randomised trial.
Rouleau JL; Pfeffer MA; Stewart DJ; Isaac D; Sestier F; Kerut EK; Porter CB; Proulx G; Qian C; Block AJ
Lancet; 2000 Aug; 356(9230):615-20. PubMed ID: 10968433
[TBL] [Abstract][Full Text] [Related]
10. Lisinopril in the treatment of congestive heart failure.
Giles TD
J Hum Hypertens; 1989 Jun; 3 Suppl 1():83-7. PubMed ID: 2550647
[TBL] [Abstract][Full Text] [Related]
11. Lisinopril. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure.
Lancaster SG; Todd PA
Drugs; 1988 Jun; 35(6):646-69. PubMed ID: 2844497
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
[TBL] [Abstract][Full Text] [Related]
13. Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group.
Packer M; Poole-Wilson PA; Armstrong PW; Cleland JG; Horowitz JD; Massie BM; Rydén L; Thygesen K; Uretsky BF
Circulation; 1999 Dec; 100(23):2312-8. PubMed ID: 10587334
[TBL] [Abstract][Full Text] [Related]
14. Low doses vs. high doses of the angiotensin converting-enzyme inhibitor lisinopril in chronic heart failure: a cost-effectiveness analysis based on the Assessment of Treatment with Lisinopril and Survival (ATLAS) study. The ATLAS Study Group.
Sculpher MJ; Poole L; Cleland J; Drummond M; Armstrong PW; Horowitz JD; Massie BM; Poole-Wilson PA; Ryden L
Eur J Heart Fail; 2000 Dec; 2(4):447-54. PubMed ID: 11113723
[TBL] [Abstract][Full Text] [Related]
15. Lisinopril in the treatment of congestive heart failure in elderly patients: comparison versus captopril.
Morisco C; Condorelli M; Crepaldi G; Rizzon P; Zardini P; Villa G; Argenziano L; Trimarco B
Cardiovasc Drugs Ther; 1997 Mar; 11(1):63-9. PubMed ID: 9140680
[TBL] [Abstract][Full Text] [Related]
16. The impact of beta-receptor blocker addition to high-dose angiotensin-converting enzyme inhibitor-nitrate therapy in heart failure.
Levine TB; Levine AB; Keteyian SJ; Narins B
Clin Cardiol; 1998 Dec; 21(12):899-904. PubMed ID: 9853182
[TBL] [Abstract][Full Text] [Related]
17. First-dose response to angiotensin-converting enzyme inhibition in congestive cardiac failure: a Malaysian experience.
Navookarasu NT; Rahman AR; Abdullah I
Int J Clin Pract; 1999; 53(1):25-30. PubMed ID: 10344062
[TBL] [Abstract][Full Text] [Related]
18. Placebo-controlled study of lisinopril in congestive heart failure: a multicentre study.
Chalmers JP; West MJ; Cyran J; De La Torre D; Englert M; Kramar M; Lewis GR; Maranhao MF; Myburgh DP; Schuster P
J Cardiovasc Pharmacol; 1987; 9 Suppl 3():S89-97. PubMed ID: 2442560
[TBL] [Abstract][Full Text] [Related]
19. A double-blind comparison of lisinopril with captopril in patients with symptomatic congestive heart failure.
Powers ER; Chiaramida A; DeMaria AN; Giles TD; Hackshaw B; Hart W; Haugland M; Johnston R; Katz R; Kirlin P
J Cardiovasc Pharmacol; 1987; 9 Suppl 3():S82-8. PubMed ID: 2442559
[TBL] [Abstract][Full Text] [Related]
20. Lisinopril and captopril in the treatment of heart failure in older patients. Comparison of a long- and short-acting angiotensin-converting enzyme inhibitor.
Giles TD; Fisher MB; Rush JE
Am J Med; 1988 Sep; 85(3B):44-7. PubMed ID: 2844087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
